Find out about the trial its history and the team
Recruitment, press and media and early results
Downloads, videos, advice and information.
Call us, email us, follow on Twitter & YouTube
We are looking to recruit over 3000 participants for the CaPP3
Study and would like to involve as many interested parties as
possible. If you are interested in joining the trial please fill in
the form below and we will contact when the trial is ready for
To show interest in participating in the trial please enter your details below.
The following fields are all optional. We are looking to gauge interest in the trial at the moment and any information you provide will be used to contact you in the future to discuss the trial and how to sign up.
Prof Sir John Burn's expert views on aspirin included in an
article in The Mail on Sunday dated August 19, 2012
CaPP3: progress towards a launch in 2013
Research has finally provided proof that taking a regular dose
of aspirin reduces the long-term risk of cancer in people with a
family history of the disease by around 60 per cent.
Institute of Genetic Medicine
International Centre for Life
Newcastle upon Tyne, NE1 3BZ
CAPP3 © 2011 | Web Development by Chocolate Grape